In the US, patients diagnosed with noninfectious uveitis (NIU) are higher in number than infectious uveitis (IU). In 2022, ...

In February 2025, BioRestorative Therapies announced that the FDA cleared its Investigational New Drug (IND) application for ...

Aim To evaluate the long-term outcomes of intravitreal triamcinolone acetonide (TA) administration after posterior vitreous detachment (PVD) during pars plana vitrectomy (PPV) for patients with ...

Pacira BioSciences, Inc. (NASDAQ: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to transform the lives of patients, today announced the debut of a powerful new ...

Am J Health Syst Pharm. 2005;62(5):485-491. A stock solution of triamcinolone acetonide standard m was prepared in ethanol and diluted to yield concentrations of 2, 4, 8, 12, and 16 µg/mL ...

Find Injective (INJ) price predictions for 2025, 2026 and 2030. Discover key investment factors, risks and analyst forecasts for this leading DeFi blockchain.

LONDON, UK – 24–25 June 2025. Projected to reach $1,139.4 billion by 2029, the injectable drug delivery market is rapidly growing—but what’s driving this evolution?

SAE Media Group's 15th Annual Pre-Filled Syringes and Injectable Drug Devices Conference 2023 will be bigger than ever, with a pre-conference focus day exploring the advances in PFS design for ...

Triamcinolone (Kenalog) is not licensed for eye use but has been used to treat DMO for over 10 years. Triamcinolone ... similar efficacy as ranibizumab combined with laser in pseudophakic eyes.21, 46 ...

Injection of a hydrogel loaded with drugs with simultaneous anti-inflammatory and tissue regenerating properties can be an effective treatment for promoting periodontal regeneration in periodontitis.

C Rob Brantly Injury: Right lat strain IL date: April 21 (transferred to 60-day IL on May 24) Expected return: TBD Status: Began rehab assignment on June 17 with Triple-A Jacksonville, going hitless ...